{"@context":"https://schema.org","@type":"Article","headline":"Part 2 undercover-placement notice exception","description":"Learn the two assertions that can change director notice for a Part 2 undercover placement application and the evidence owners should preserve.","url":"https://finnihealth.com/resources/glossary/part-2-undercover-placement-notice-exception","datePublished":"2026-08-17T00:00:00.000Z","dateModified":"2026-08-24T00:00:00.000Z","author":{"@type":"Organization","name":"Finni Health Editorial Team"},"publisher":{"@type":"Organization","name":"Finni Health","url":"https://www.finnihealth.com"},"isPartOf":{"@type":"CollectionPage","name":"ABA and Practice Operations Glossary","url":"https://www.finnihealth.com/resources/glossary"},"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Resources","item":"https://www.finnihealth.com/resources"},{"@type":"ListItem","position":2,"name":"Glossary","item":"https://www.finnihealth.com/resources/glossary"},{"@type":"ListItem","position":3,"name":"Part 2 undercover-placement notice exception","item":"https://finnihealth.com/resources/glossary/part-2-undercover-placement-notice-exception"}]}}
Glossary term

Part 2 undercover-placement notice exception

Learn the two assertions that can change director notice for a Part 2 undercover placement application and the evidence owners should preserve.

5
min read
Updated
August 23, 2026
Sources checked
August 23, 2026
ยท View sources
Also called

SUD director involvement notice exception undercover placement disclosure risk

A placement notice exception under 42 CFR 2.67 applies when an undercover-order application asserts that the Part 2 program director is involved in the suspected criminal activity or would intentionally or unintentionally reveal the proposed placement to suspected employees or agents. The exception changes director notice; the court still evaluates the application and required findings.

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.67(b) identifies two circumstances asserted in an application for withholding ordinary director notice: the program director is involved in the suspected criminal activity, or the director would intentionally or unintentionally reveal the proposed placement to suspected employees or agents. The application and court process determine the route.

The rule names two distinct risks

The first 42 CFR 2.67 assertion concerns the director's suspected involvement. The second concerns disclosure of the placement to suspected people, whether intentional or inadvertent. Record which assertion applies and the facts offered for that route.

The court process remains controlled

Preserve the application, supporting declaration, requested notice treatment, sealing terms, court decision, authorized recipients, implementation instructions, and later changes. Staff should follow the actual order rather than infer secrecy from an investigation label.

Operational access should match the ruling

Limit matter access to named legal and investigative roles. Protect calendars, invoices, email subjects, shared drives, help-desk tickets, and vendor notifications that could expose the filing or placement. Log each authorized disclosure and exception.

Classify the asserted exception

Identify the director, suspected personnel, alleged activity, proposed placement, and exact exception being asserted. Separate claimed director involvement from claimed disclosure risk. If both apply, support each independently. A strained relationship, possible objection, operational inconvenience, or desire for secrecy does not match the rule's text by itself.

Record uncertainty and contrary facts. Counsel and the court need a balanced evidentiary record, not a conclusory label.

Support director-involvement facts

Document the conduct, role, timing, sources, and connection between the director and suspected criminal activity. Distinguish knowledge, supervision, administrative responsibility, negligence, and alleged participation. Use evidence obtained through lawful means and protect patient-identifying information.

Avoid circulating allegations to program personnel or adding protected clinical records that are unnecessary to the issue. Preserve source provenance for judicial review.

Support disclosure-risk facts

Explain why notice would create a material risk that the director would intentionally or unintentionally tell suspected employees or agents about the placement. Address reporting lines, access, communication patterns, required operational coordination, prior conduct, and proposed role. General speculation about workplace conversation is weak support.

Consider whether narrower notice, timing, sealed materials, limited disclosure, or another court-directed measure could protect the investigation while preserving procedure.

Restrict the application and ruling

Use a limited counsel team, sealed or restricted filing where ordered, protected declarations, controlled service, and secure evidence. Inspect docket text, metadata, case-management notifications, vendor access, calendars, and remote-hearing links. Record the court's decision on notice and the exact order version.

Do not infer broader secrecy or investigative powers from the notice ruling. Other good-cause and order-content requirements remain.

Reassess before placement

Confirm the director identity, leadership status, suspected-personnel set, and disclosure facts have not changed. If the factual basis weakens or a different person becomes director, pause and seek counsel and court direction. Preserve amendments and updated findings.

Train only authorized handlers on the notice restriction. An internal scheduling or credentialing message can defeat the protected route even when the court file is sealed.

Prevent exception leakage during setup

Map every person and system needed to create the role, credentials, schedule, workspace, payroll or patient registration, device, and access. Use court- and counsel-approved explanations, minimum privileges, delayed activation, and restricted tickets. Review automated welcomes, directory entries, background checks, staff rosters, billing records, patient portals, and vendor notices. Escalate any operational step that would reveal the placement or require false clinical documentation beyond the authorized plan.

Verify cleanup of test accounts and abandoned setup records.

Example with exception requests

Five applications request a notice exception. Four identify one or both regulatory assertions and preserve the supporting evidence; one uses a general confidentiality statement. Exception-request completeness is 4 of 5 applications.

Owner controls

The 2024 final rule retained this structure. Use qualified counsel, fact-specific declarations, sealed files, least-role access, court-decision tracking, and an escalation path for accidental disclosure.

Notice-exception checklist

  • identify the director, suspected personnel, and precise asserted exception;
  • distinguish involvement from intentional or unintentional disclosure risk;
  • preserve lawful, current supporting facts and contrary evidence;
  • minimize patient information and restrict applications, dockets, and vendors;
  • record the court's notice ruling without expanding its effect; and
  • reassess leadership and disclosure facts before operational placement.

The exception is fact-specific and court-centered. It should be no broader than needed to address the documented director-related risk.

Related terms

Sources

Beyond the glossary

Take the next step with clarity

Whether you are finding care, growing as a clinician, or building a stronger ABA practice, Finni brings the people, tools, and support together to help you move forward.

Start or grow your ABA practice with Finni